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Abstract
Hepatitis C virus (HCV) is a blood-borne pathogen and a major cause of liver disease worldwide. Gene expression profiling was
used to characterize the transcriptional response to HCV H77c infection. Evidence is presented for activation of innate antiviral
signaling pathways as well as induction of lipid metabolism genes, which may contribute to oxidative stress. We also found
that infection of chimeric SCID/Alb-uPA mice by HCV led to signs of hepatocyte damage and apoptosis, which in patients plays
a role in activation of stellate cells, recruitment of macrophages, and the subsequent development of fibrosis. Infection of
chimeric mice with HCV H77c also led an inflammatory response characterized by infiltration of monocytes and macrophages.
There was increased apoptosis in HCV-infected human hepatocytes in H77c-infected mice but not in mice inoculated with a
replication incompetent H77c mutant. Moreover, TUNEL reactivity was restricted to HCV-infected hepatocytes, but an increase
in FAS expression was not. To gain insight into the factors contributing specific apoptosis of HCV infected cells,
immunohistological and confocal microscopy using antibodies for key apoptotic mediators was done. We found that the ER
chaperone BiP/GRP78 was increased in HCV-infected cells as was activated BAX, but the activator of ER stress–mediated
apoptosis CHOP was not. We found that overall levels of NF-kB and BCL-xL were increased by infection; however, within an
infected liver, comparison of infected cells to uninfected cells indicated both NF-kB and BCL-xL were decreased in HCV-
infected cells. We conclude that HCV contributes to hepatocyte damage and apoptosis by inducing stress and pro-apoptotic
BAX while preventing the induction of anti-apoptotic NF-kB and BCL-xL, thus sensitizing hepatocytes to apoptosis.
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Introduction
Hepatitis C virus (HCV) is a positive strand RNA virus that
belongs to the family Flaviviradae. HCV is a blood borne pathogen
which is a major cause of liver disease worldwide, with an
estimated 200 million people infected. It is estimated that 30% of
chronically infected patients eventually develop progressive liver
disease including cirrhosis and end stage liver disease [1]. HCV is
now the leading indication for liver transplantation in North
America [2]. Due the absence of a proofreading activity in the
viral RNA polymerase, HCV has a high mutation rate that
contributes to the genetic heterogeneity of the virus. Six different
genotypes, and at least 52 subtypes have been described [3].
Chronic infection by HCV results in a highly variable disease
course, and despite advances in the molecular virology of HCV,
the factors involved in hepatocyte injury and the progression of
liver disease remain unclear. The complexity of the host response
has been examined by transcriptional profiling of liver biopsy
samples from both chimpanzees and humans. These studies show
that HCV induces genes involved in the interferon response, lipid
metabolism, oxidative stress, and chemokines, as well as markers
of inflammation [4,5]. Such studies are hampered by the
requirement that infected and uninfected hepatocytes come from
different patients and also by the presence of an adaptive immune
response in the patients. Gene expression profiles of human
hepatocytes from SCID/Alb-uPA chimeric mice infected with HCV
patient serum, control these variables [6]. Until recently it has
been thought that HCV is a non-cytopathic virus and that
hepatocyte damage in chronic HCV infection is due to HCV-
specific adaptive immune responses [7,8]. However, in SCID mice
lacking an adaptive immune system, we observed induction of
apoptosis in HCV infected mouse livers, similar to that seen in
liver biopsies from HCV infected patients [6].
During HCV infection, hepatocyte apoptosis could be induced by
immune attack on infected cells or directly by viral infection. It has
been shown that hepatocyte damage can lead to apoptosis, which
plays a role in the recruitment and activation of stellate cells and
macrophages and the subsequent development of fibrosis [9,10].
HCV infected patients have higher levels of immune related death
ligands; TRAIL, TNF-a, FAS, and FASL are all elevated in HCV
infected patients [11–13]. Increased expression of stimulators of
apoptosis in HCV infected patients is tempered by hepatocyte
insensitivity to death ligand mediated apoptosis. In hepatocytes death
receptor mediated caspase-8 activation is weak, and thus they are
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cytes are likely type II cells and can be sensitized to death ligand
mediated apoptosis by caspase-8 induction with IFN-a (interferon) or
toxins [16–18]. In addition, hepatocytes can be sensitized to both
TRAIL and TNF-a induced apoptosis by inhibition of NF-kB
activity [19–21]. Conversely, induction of NF-kBh a sb e e ns h o w nt o
inhibit TRAIL, TNF-a, and FAS mediated killing [22–24].
The induction of apoptosis directly by HCV remains contro-
versial. Several HCV proteins have been proposed to have both
pro- and anti-apoptotic effects [25–28]. It has been shown that
expression of either the HCV genome or individual HCV
structural proteins induces endoplasmic reticulum (ER) stress
[27,29] and the unfolded protein response (UPR), which can lead
to apoptosis. However, HCV proteins have also been shown to
modulate the UPR [30,31]. It has also been proposed that HCV
infection induces oxidative stress, which can enhance apoptosis
[6,32]. Expression of HCV core induces oxidative stress and
expression of antioxidant genes [33,34]. In addition, HCV patients
have more DNA lesions produced by oxidative damage [35].
Oxidative stress leads indirectly from DNA damage to p53
induction, which can lead to activation of BAX and apoptosis
[36,37]. However, there are also reports of inhibition of p53
induced apoptosis by NS5A [38–41].
In this study, we used the mouse model for HCV infection in
which severe combined immunodeficiency disorder (SCID) mice
transgenic for an array of urokinase plasminogen activator (uPA)
under control of the albumin (Alb) promoter are transplanted with
human hepatocytes and then infected with HCV [6,42–44]. We
have previously compared HCV induced gene expression in
chimeric mice infected with genotype 1a patient serum to
uninfected controls containing human hepatocytes from the same
donor [6]. There was evidence of activation of innate antiviral
signaling pathways, induction of lipid metabolism genes, as well as
signs of hepatocyte damage and an inflammatory response. To
further reduce variation from HCV quasispecies present in the
mice, in this study we have infected mice with the infectious clone
HCV H77c [45,46]. We confirmed the results of the previous
study that used infectious patient serum, and to determine the
cause of hepatocyte damage, we examined the expression HCV
antigens and key proteins involved in the stress response and
apoptosis using immunohistochemical and fluorescent confocal
microscopy. We found that HCV infection correlated with
increased levels of the ER chaperone GPR78/BiP, a key regulator
of the unfolded protein response. In addition, levels of pro-
apoptotic BAX were increased, while anti-apoptotic NF-kB and
BCL-xL were decreased in HCV infected cells. Taken together
these results indicate that ER stress induced by HCV combined
with lower NF-kB and BCL-xL levels sensitizes hepatocytes to
apoptosis.
Results
Previous studies indicated HCV infection in chimeric mouse
livers was restricted to the human hepatocytes [44]. We confirmed
this by performing immunofluorescent confocal microscopy on
uninfected and HCV H77c infected mouse livers with antibodies
specific for the HCV NS3 protease and human albumin (Figure 1
and S1A–B). Only liver sections infected with HCV H77c stained
with HCV specific antibodies, and this was restricted to hepatocytes
that also were also stained with antibodies specific for human
albumin. Since liver consists of a mix a hepatocytes and adventitial
cells, and albumin only stains hepatocytes, there was the possibility
that some human cells other than hepatocytes also colonized the
mouse liver. Therefore we wished to examine whether any of the
adventitial cells were also human. We performed in situ hybridiza-
tion using probes specific for human Alu repeats on chimeric mouse
livers (Figure 2). Only the hepatocytes were stained, indicating all of
the adventitial cells in chimeric mouse livers were of mouse origin.
This, and the elimination of a small percentage of mouse sequences
that cross-hybridized to the human arrays, ensured that the
transcriptional profiling reflects only the processes occurring in
human hepatocytes.
Transcriptional profiling was performed on mRNA samples
isolated from three HCV-infected animals and from uninfected
controls. All animals contained hepatocytes from a single donor.
The serum HCV titers, liver viral loads, and the length of time
infected are given in Table 1. The experiments included three liver
samples from an animal infected with H77c (+) serum (990), two
samples from an animal inoculated intrahepatically with H77c
RNA (975), and a single experiment with liver tissue from an
animal inoculated intrahepatically with H77c RNA containing a
mutation in the active site of the NS5B polymerase (986). Four
samples from three separate animals were pooled to serve as the
uninfected control. Because each pair of mice contained
hepatocytes from the same donor, changes in gene expression
should mainly be induced by the HCV infection and be
independent of host variation. Consistent with previous studies,
the effect on host gene expression by HCV infection was not
extreme, 766 genes showed a 2-fold or higher change in expression
(P value#0.05) in at least one experiment (Figure 3). The grouping
of experiments by the clustering algorithm suggested that the effect
on host gene expression was very similar among individual pieces
of liver from the same animal. Importantly, the global gene
expression profiles in the animals infected with H77c (+) serum
(990) and H77c RNA (975) were also very similar. This suggests
that the source of HCV inoculum does not significantly impact the
host transcriptional response to infection. Interestingly, the animal
inoculated with H77c RNA encoding an inactive NS5B
polymerase also showed a similar host response. While it was
expected that the mouse inoculated with the replication defective
HCV RNA might show activation of dsRNA and RIG-I signaling
pathways similar to replicating virus [47,48], we expected
substantial differences in the overall host response 47 days after
RNA administration. This mouse showed no detectable HCV
RNA in the serum at the time of sacrifice and no HCV RNA was
detected in the sample used for microarray analysis.
Infection with HCV H77c activated innate antiviral signaling
pathways, as indicated by the induction of interferon-stimulated
genes (ISGs) (Figure 4A). In general, the induction was similar
among all three infected animals. However, there does seem to be
a slightly higher induction of ISGs in the animal (975) inoculated
intrahepatically with wild-type H77c RNA relative to the animal
(990) inoculated with H77c (+) serum, which is likely due to the
high level of naked RNA injected directly into the liver of this
Author Summary
Hepatitis C virus is a common cause of liver disease
worldwide. The details of how HCV causes liver disease are
not well understood. It has been thought that HCV
infection does not kill liver cells directly, but indirectly by
stimulating the immune system to kill HCV-infected liver
cells. In this study we have used a mouse model that
supports HCV infection and replication. These mice do not
have an adaptive immune system. Despite the lack of an
adaptive immune system, we have shown that HCV
infection still leads to the death of infected liver cells. This
study provides new insight into how HCV damages the
liver in chronic HCV carriers.
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13 copies). This increased response relative
the animal inoculated with serum (990) was not observed in the
animal (986) injected with H77c RNA containing inactive NS5B,
indicating that part of the increased response in animal 975 might
be due to replication of the inoculated HCV RNA. In our previous
study of mice infected with HCV-positive patient sera the
magnitude of induction of ISGs varies among mice containing
hepatocytes from different donors. Comparison of the gene
expression data from HCV H77c-infected mice with that from
the initial study indicate the induction of ISGs in the H77c-
infected mice is relatively weak. Consistent with what was
observed in animals with a weak IFN response in the initial study,
regulation of numerous genes associated with lipid metabolism
were observed in the HCV H77c-infected mice (Figure 4B). These
included genes involved in cholesterol and fatty acid biosynthesis,
b-oxidation and peroxisome proliferation. There did not appear to
be any significant differences due to inoculum source. Interest-
ingly, the animal that received replication incompetent H77c
RNA also showed some regulation of these genes, although at a
lower magnitude. The fact that this mouse shows any changes at
all, in the absence of viral replication, may be because injection of
viral RNA from a positive-sense RNA virus likely results in the
synthesis of viral proteins.
Consistent with the up regulation of genes involved in oxidative
stress seen in this and previous expression array studies,
histological analysis revealed signs of hepatocyte damage in the
human hepatocytes of HCV infected chimeric mice (Table 2).
Steatosis was apparent in the majority of the human hepatocytes
regardless of infection. However, there were significant differences
in the histology between the animals inoculated with HCV RNA
and naive animals. Increased hepatocyte ballooning and lobular
inflammation were associated with HCV-infection. Staining of
sections with the antibody F4-80 (anti CD68) revealed that the
lobular inflammation was due to infiltration of monocytes and
macrophages (not shown). A particularly intriguing observation
was the presence of apoptotic hepatocytes in HCV-infected
animals originally detected as caspase-3 activation and quantita-
tion of apoptotic bodies [6]. We also observed apoptosis in H77c-
infected mice by TUNNEL assay (Figure 5D–F). Apoptosis was
absent in the animal inoculated with the replication defective
H77c-AAA mutant. This suggests that apoptosis observed in
HCV-infected mice is dependent upon active HCV replication.
The expression of genes associated with cell death was analyzed to
gain further insight into possible mechanisms of apoptosis. While
there was regulation of cell-death related genes in HCV H77c
infected animals, the number of genes affected is small (data not
shown). This is perhaps not surprising given the low percentage of
hepatocytes that are actually undergoing apoptosis. Quantitation
of the TUNEL data in Table 2 (average 723 cells/field) revealed
on average 5% of cells undergoing apoptosis in infected mice.
To further investigate the mechanism of increased apoptosis
associated with HCV infection, we examined FAS expression on
liver sections from infected and uninfected mice and compared
this to liver sections subjected to TUNEL analysis. Similar to what
has been seen in mice infected with patient serum and in patient
biopsies [6], there was increased FAS staining in infected
compared to donor matched uninfected mice (Figure 5A–C). As
can be seen in Figure 5 and at higher magnification in Figure S2,
there was strong FAS reactivity in a majority of the human cells in
infected mice, however TUNEL positive nuclei were seen only in a
small proportion of human cells (Figure 5D–F). Interestingly,
although staining was not as intense, there was an increase in FAS
staining in the mouse inoculated with the H77c-AAA mutant,
without a correlative increase in the TUNEL positive nuclei
(Table 2). This suggests that increased FAS expression is not the
only factor required for induction of apoptosis and TUNEL
reactivity. We next investigated the correlation between HCV
infection, and either FAS expression, or TUNEL reactivity. When
we stained liver sections with FAS- and HCV-specific antibodies
(Figure 6A), we found that expression of FAS does not depend on
the presence of HCV in the cells, but is a host reaction to infection
of neighbouring cells. However, we cannot rule out the possibility
that only a portion of cells in the liver express enough HCV
antigen to be detected using this antibody. When we subjected
Figure 2. In situ hybridization with human specific Alu DNA
oligonucleotides. In situ hybridization using human Alu DNA probes,
with the nuclei were counter stained using methyl green, showing a
lobular region (A), and portal triad (B). Magnification 6400.
doi:10.1371/journal.ppat.1000291.g002
Figure 1. Confocal microscopy of uninfected and HCV H77c infected mouse livers stained with anti-HCV and anti-human albumin.
Confocal microscopy was performed on either uninfected (A) or H77c infected (B–F) liver sections. Sections were either singly stained (A, B) using
mouse monoclonal antibodies against HCV or, to differentiate between the human and mouse hepatocytes, rabbit anti human albumin antibodies in
addition (D–F). Isotype controls (C) were also used to stain a serial section to panel D (See also figure S1 A, B). The nuclei were stained with DAPI
(blue), and mouse antibodies were visualized using secondary goat anti-mouse poly-HRP antibodies followed by tyramide-TMR (red). The rabbit
antibodies were visualized using secondary goat anti-rabbit-alexa 488 (green) antibodies. Junctions between human and mouse cells is shown in two
magnifications in panels E and F.
doi:10.1371/journal.ppat.1000291.g001
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with HCV specific antibodies, we found that all of the TUNEL
positive cells in areas populated by human hepatocytes also stained
with HCV specific antibodies (Figure 6B). The exception was that
some murine Kupffer cells which also contained multiple TUNEL
positive nuclei. Thus, HCV replication seems to be required for
hepatocyte apoptosis. This is unlike FAS expression, which could
be induced by HCV replication in neighbouring cells.
To further investigate the relationship between HCV infected
cells and apoptosis we performed immunohistochemistry and
fluorescent confocal microscopy using antibodies for key proteins
involved in apoptosis. It has been proposed that HCV induces
oxidative stress [6,32]. Oxidative stress can lead to the induction of
p53 and BAX, both of which can translocate to the mitochondria
and induce apoptosis [36,37]. We performed immunohistological
staining for p53 on infected and uninfected liver sections and
found no evidence for p53 induction in either the cytoplasm or
nucleus or its translocation to the mitochondria except in one
infected animal where very few cells appeared to have up-
regulated p53 (data not shown).
Expression of HCV structural proteins has been shown to
induce ER stress [27,49], which can induce the oligomerization
and translocation of BAX/BAK to the mitochondria. To examine
the role of ER stress in HCV induced apoptosis, we compared the
expression of the ER chaperone GRP78 (BiP) in uninfected and
H77c infected mice by immunohistochemistry (Table 3 and
Figure 7A–C) and by fluorescent confocal microscopy (Figure 7D,
E). We found higher levels of BiP in infected mice, and that BiP
expression correlated with HCV infection. Additionally, BiP and
HCV seemed to co-localize, consistent with replication of HCV on
the ER. The ER chaperone BiP is a key sensor in the unfolded
protein response (UPR); it maintains ER membrane signal
proteins in inactive states. It has been shown that BAX and
BAK interact directly with one of these membrane signal proteins,
IRE1, and are essential for IRE1 activation [50]. Extensive or
prolonged ER stress initiates apoptosis through activation of
BAX/BAK. We therefore examined the expression of BAX in
liver sections (Table 3 and Figure 8) and found BAX was also
overexpressed in HCV infected livers. BAX is normally diffusely
expressed throughout the cell, however when activated it
translocates to the mitochondria and appears as a granular
staining pattern. We found that both patterns of staining were
elevated in HCV infected livers (Figure 8A–D). Figure 8D shows
both the intense granular staining pattern as indicated by the black
arrows and the less intense cytoplasmic staining indicated by the
Table 1. Serum and Liver Viral Titers.
Mouse Serum titer
a (copies/ml) Average Liver load (copies/mg Human RNA) Length of Infection
Naı ¨ve:
005 undetectable undetectable Age match 30 days
963 undetectable undetectable Age match 30 days
992 undetectable undetectable Age match 47 days
996 undetectable undetectable Age match 47 days
986-AAA undetectable undetectable 47 days
638-1a Patient serum 4.7610
5 1.6610
5 25 days
975-RNA 1.3610
6 5.3610
4 47 days
985-RNA
b 1.9610
2 1.8610
2 47 days
990-H77c serum 9.5610
6 3.8610
5 47 days
aThe detection limit for this assay is 255 copies/ml.
bAlthough the serum titer was below the limit of detection at the time of death, animal 985 was infected because at days 21 and 33 post infection the titers were 1610
3
and 7.7610
3, respectively.
doi:10.1371/journal.ppat.1000291.t001
Figure 3. Global gene expression profiles of HCV (H77c 1a)-
infected mice. Two-dimensional hierarchical clustering was performed
using Resolver System software with an agglomerative algorithm,
complete link heuristic criteria, and Euclidian correlation metric. Each
column represents gene expression data from an individual experiment
(either individual HCV-infected mouse or individual liver sample) and
the cluster represents genes that showed a .2-fold change (P
value,0.05) in at least 1 experiment. Genes shown in red were up-
regulated; genes shown in green down-regulated and genes in black
indicate no change in expression in HCV-infected tissue relative to a
pool (3 individual animals) of donor-matched uninfected tissue. Animal
990 was infected with H77c (+) serum. Animal 975 received 100 mgo f
H77c RNA by intrahepatic injection while animal 986 received 100 mgo f
H77c RNA containing the GDD-AAA mutation in the NS5B coding
region.
doi:10.1371/journal.ppat.1000291.g003
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HCV infection (Figure 8F). It is worth noting that not all cells that
stained positive for HCV also showed activated BAX. The
number of cells staining for activated BAX approximately
correlated with the number of TUNEL positive nuclei. The
elevation of both BiP and BAX in the absence of increased levels
of p53 suggests that ER rather than oxidative stress leads to BAX
activation, however additional mechanisms of BAX activation by
oxidative stress cannot be eliminated.
In cells under ER stress, BiP preferentially binds to malfolded
proteins, releasing IRE1, PERK, and ATF6, activating down-
stream effectors which induce transcription of alarm and
adaptation genes including BiP itself and GADD153 (CHOP)
[51]. When the UPR is overwhelmed, apoptosis is induced by a
number of molecules including CHOP, which translocates to the
nucleus and blocks transcription of BCL-2, [52] an inhibitor of
BAX/BAK. To examine whether the ER stress found in infected
livers overwhelmed the unfolded protein response, indicated by
translocation of CHOP to the nucleus, we performed immuno-
fluorescent confocal microscopy with anti-CHOP and anti-HCV
antibodies (Figure 9). Because we found very few nuclei that
stained positively for CHOP and these did not correlate with the
staining by HCV specific antibodies, in Figure 9 both panels are
from infected mice; panel A shows a predominately infected area,
and panel B shows a predominantly uninfected area with only a
few infected cells. CHOP can be elevated in both infected and
uninfected cells indicating that HCV infection does not overwhelm
the UPR. This may explain why we do not see expression of ER
stress genes in the microarray analysis.
In addition to pro-apoptotic proteins, we also examined key
inhibitors of apoptosis. Both CHOP and NF-kB are both activated
by ER stress [53,54], but have opposing effects; CHOP is pro-
apoptotic while NF-kB is anti-apoptotic. NF-kB is activated in
response to a myriad of other stimuli, at least one of which is
inhibited by HCV [55]. BCL-xL inhibits the apoptosis induced by
BAX, and its transcription is activated by NF-kB [56]. Overall,
when HCV infected livers were compared with uninfected livers,
the levels of both NF-kB and BCL-xL appeared to be elevated in
the infected liver, consistent with expression analysis, which
indicated that NF-kB levels are elevated by HCV infection.
Figure 4. Expression of IFN-inducible and lipid metabolism genes in human liver tissue from HCV-infected mice. The gene sets were
IFN-inducible (A), or involved in lipid metabolism (B). Two-dimensional hierarchical clustering was performed using Resolver System software witha n
agglomerative algorithm, complete link heuristic criteria, and Euclidean correlation metric. Each column represents gene expression data from an
individual experiment (either individual HCV-infected mouse or individual liver sample). Genes were selected as at least 2-fold regulated (P
value,0.05) in at least 1 experiment. Genes shown in red are up-regulated and genes shown in green are down-regulated in HCV-infected tissue
relative to donor-matched uninfected tissue, while black indicates no change in gene expression. Animal 990 was infected with H77c (+) serum.
Animal 975 H77c RNA by intrahepatic injection while animal 986 received H77c RNA containing the GDD-AAA mutation in the NS5B coding region.
doi:10.1371/journal.ppat.1000291.g004
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cells within HCV infected livers, we found that total levels of NF-
kB p65 expression was lower in HCV infected cells than in
surrounding uninfected cells (Figure 10A–B and E and S4).
Quantitation of total p65 fluorescence from uninfected and
infected cells in 6 fields from infected livers revealed that p65
levels in infected cells were approximately half that in uninfected
cells. The average fluorescence of uninfected cells in a field was
arbitrarily set to 1. Consistent with reduced expression of NF-kB,
the expression of BCL-xL was also lower in cells that stained with
HCV specific antibodies (Figure 10C–D and F). Quantitation of
total BCL-xL levels in infected livers also revealed that levels of
BCL-xL in infected cells were approximately half of that in
infected cells.
Discussion
The course of HCV pathophysiology is extremely variable, as a
result of complex interactions between viral variants and the host’s
innate and adaptive immune systems. We have used SCID/Alb-
uPA mice that have chimeric human and mouse livers to examine
the processes that occur in hepatocytes in response to HCV
infection. Previous studies have shown that the transcriptional
response HCV infection in mice is similar to that of humans and
chimpanzees, with the exception of immune cell markers, which
are absent in SCID mice. To further simplify the host response to
infection, we infected mice with RNA from the HCV clone H77c
[45,46]. We found the same induction of interferon response genes
and changes in expression of genes involved in lipid metabolism
Table 2. Immunohistological Evaluation of Liver Sections.
Mouse Fat
a Balloon
b Grade
c Stage
c FAS
d LAB
e Caspase
d Tunel
f
Naive:
005 0 0 0(P0 L0) 0 2 0.2 0 362
963 2 1 0(P0 L0) 0 1 0 0 863
992 3 0 2(P0 L2) 0 3 0 2 m 863
996 2 0 2(P0 L2) 0 2 0 2 m 1162
986-AAA 2 2 3(P0 L3) 0 3 0 0 1064
638-1a Patient serum 0 3 2(P0 L2) 0 4 0.4 2 m 1862
985-RNA 3 3 3(P0 L3) 0 3 1.6 3 m, h 50614
975-RNA 2 3 3(P0 L3) 0 4 4 3 m, h 26613
990-H77c serum 3 2 2(P0 L2) 0 4 0.4 2 m 50613
aThe degree of fatty change was scored as 0 (,5%), 1 (6–33%), 2 (34–66%) 3 (.66%).
bHepatocyte ballooning was scored on a scale of 0–4 where 0 is none and 4 is many.
cGrade and Stage were scored using the Batts and Ludwig criteria.
dFAS and caspase staining was scored semi-quantitatively where 0=none, 1=focal weak, 2=diffuse weak; 3=diffuse weak and focal strong; 4=diffuse strong. For
caspase staining, m is macrophages and h is hepatocytes.
eThe lobular apoptotic body count is an average of 5 fields counted at magnification 6100.
fThe number of Tunel positive nuclei is an average of 15 fields at magnification 6200.
doi:10.1371/journal.ppat.1000291.t002
Figure 5. Immunohistochemical analysis of FAS expression and TUNEL reactivity. Liver sections from PBS injected (A and D), replication
deficient RNA injected (B and E) and HCV H77c infected (C and F) donor matched chimeric mice were stained using rabbit anti-FAS (A–C), developed
using the Vecastain ABC kit and counterstained using haematoxylin. Isotype controls were negative and are shown in Figure S1C–D. TUNEL (D–F) was
performed using the Apoptag Plus Peroxidase In Situ Apoptosis Detection kit and the nuclei were counterstained with methyl green. Magnification
6100. Arrows indicate TUNEL reactive nuclei. In panel F, arrows indicate only some of the TUNEL reactive nuclei.
doi:10.1371/journal.ppat.1000291.g005
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generation of oxidative stress [6,57], and it has been shown that
both oxidative stress and ER stress can lead to apoptosis
[27,29,58,59]. As well, apoptosis is one of the factors in the
induction of fibrosis, which can culminate in cirrhosis [9,10,60,61].
Interestingly, in the absence of an adaptive immune system, there
was evidence for the induction of apoptosis in HCV infected mice.
This was restricted to HCV infected cells despite increased FAS
expression on both infected and uninfected human hepatocytes of
infected animals. This generalized FAS expression may be a
consequence of the interferon response occurring throughout the
liver [6] since FAS/FASL are among those mediators of apoptosis
that are also interferon response genes [62].
We therefore examined processes leading to apoptosis that we
thought were likely to be affected by HCV in infected cells.
Oxidative stress generated by HCV induced lipid metabolism, and
ER stress generated by HCV replication and protein translation in
and on the ER were both potential candidates. Hepatocytes are
type II cells that contain low levels of caspase 8 and therefore
require activation of the mitochondrial apoptosis amplification
pathway to initiate apoptosis. This can be blocked by over
expression of BCL-2 or BCL-xL. Mitochondria seem to be the site
where the antiviral interferon response and apoptotic signals are
integrated; recently it has been shown that the mitochondrial
signaling molecule interferon promoter stimulating factor-1 (IPS-1)
is cleaved during apoptosis and cleavage can be blocked by
overexpression of BCL-xL [63]. In addition, both the response to
oxidative stress and the response to ER stress converge at the
mitochondrion; p53 activated by oxidative stress stimulates the
oligomerization of BAX [36], and BiP responding to ER stress
releases IRE-1 to which BAX is bound. BAX has been shown to
be required for both IRE-1 activation and for apoptosis initiated
by ER stress [50,51]. Since oxidative stress can lead to p53
induction, Bax activation and apoptosis [36,37], we examined p53
localization and levels and found that they were not affected by
HCV infection. This may be due to NS5A mediated inhibition of
the mitochondrial translocation, apoptosis inducing, and DNA
binding activities of p53 [38–41]. ER stress can lead to induction
of the UPR, and activation of BiP, CHOP, BAX and apoptosis.
Consistent with the generation of ER stress by HCV we found that
induction of the ER chaperone BiP and pro-apoptotic BAX
correlated with HCV expression, but there was little translocation
of CHOP/GADD153 to the nucleus, which indicated that the
UPR was not overwhelmed.
In hepatocytes, it appears that NF-kB is one of the key
determinants of whether apoptosis is induced in response to death
ligands [19–24,64]. In evading of the interferon response, HCV
Figure 6. Confocal microscopic analysis of HCV antigen
expression and either FAS expression or TUNEL reactivity.
Staining for FAS (A) or TUNEL reactivity (B) was performed as described
in Materials and Methods, using primary mouse anti-HCV and either
rabbit anti-human FAS (A), or for TUNEL, FITC labeled dUTP and
terminal deoxynucleotidyl transferase (B). The secondary antibodies
were goat anti mouse poly-HRP, and for FAS staining, goat anti rabbit
Alexa-488 (green). HRP was developed using the TSA plus fluorescence
system with tyramide-TMR (red). Nuclei were stained using DAPI (blue).
Arrows indicate TUNEL reactive nuclei.
doi:10.1371/journal.ppat.1000291.g006
Table 3. Immunohistochemical Evaluation of Liver Sections
Stained with Bip/GRP78 or Bax.
Mouse BiP/GRP78 BAX
Punctate
BAX
b
Cell number
a
(Intensity)
Cell number
a
(Intensity) Cell number
Naive:
005 1 (1) 1 (1) 1
963 2 (2) 1 (1) 1
992 1 (1) 2 (1) 2
996 1 (3-infiltrate) 0 (0) 0
638-1a Patient
serum
2 (2) 2 (2) 2
986-AAA 1 (3-infiltrate) 2 (1) 0
985-RNA 3 (1) 3 (3) 3
975-RNA 2 (2) 2 (2) 3
990-Serum 3 (2) 2 (2) 2
aStaining was scored semi-quantitatively where 0 is no staining 1 (1–15%), 2
(16–30%), and 3 (31–50%), and the intensity of staining was scored on a scale
of 0–3, where 0 is no staining and 3 is intense staining.
bActivated BAX has a distinct punctate staining which is easily distinguished
form inactive BAX, 0 is no staining, 1 (1–5%), 2 (5–10%), and 3 (10–15%).
Activated Bax has a uniform intense staining and so no intensity score was
given.
doi:10.1371/journal.ppat.1000291.t003
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I pathways by cleavage of TRIF and IPS-1/MAVS/VISA/Cardif
by the HCV NS3/4A protease, inhibits NF-kB and IRF-3
phosphorylation preventing nuclear translocation in response to
RIG-1 activation by viral RNA [65–68]. In addition, there are a
number of other reports that HCV modulates NF-kB activity [69–
72]. Consistent with the reports of inhibition of NF-kB we found
that total levels of NF-kB p65 were lower in HCV infected cells.
Furthermore consistent with the transcriptional regulation of BCL-
xL by NF-kB, we found that total levels of BCL-xL were lower in
HCV infected cells. In conclusion, we propose a model (Figure 11)
where HCV induces both ER stress and oxidative stress in infected
cells, and activates pro-apoptotic Bax while it prevents induction of
anti-apoptotic BCL-xL thus sensitizing HCV infected cells to
apoptosis which may be mediated by death receptors and ligands,
for example FAS and TRAIL (TNFSF10-Figure 4B). A combi-
nation of induction of pro-inflammatory chemokines (Figure 4A)
and cross talk between human and mouse chemokines and their
receptors may lead to a situation similar to that in patients;
inflammation, which in turn stimulates release of pro-inflamma-
tory cytokines and effector molecules such as TNF-a and FasL
(which in these mice may be released by macrophages and NK
cells), creating the circle of hepatocyte damage and repair that is a
hallmark of HCV infection.
Materials and Methods
Transplantation and infection of chimeric SCID/Alb-uPA
mice
All mice were housed VAF and treated according to Canadian
Council on Animal Care guidelines. Experimental approval came
from the University of Alberta Animal Welfare Committee, and
human hepatocytes were obtained following informed consent of
all donors with ethics approval from the University of Alberta
Faculty of Medicine Research Ethics Board. Animals were
transplanted with freshly isolated human hepatocytes [42,44,73].
Eight weeks after transplantation mice with human a-1antitrypsin
(hAAT) levels [42] greater than 100 mg/mL were injected
intrahepatically (ih), with 50 mgo fin vitro transcribed H77c RNA
[45] into each of 2 red liver nodules (presumed to be human
hepatocytes). As a negative control, mice were injected ih with
non-replicative H77c RNA in which NS5B polymerase active site
residues GDD (amino acids 2736–2738) have been changed to
AAA (H77c-AAA). Passage of H77c virus was done by ih
inoculation of naive mice with 50 mL of serum obtained from
mice infected by H77c RNA. One mouse was infected by ih
inoculation with patient serum for histochemical comparison.
Serum samples were taken at various time points after inoculation
and HCV RNA was quantified. Animals were infected for 25 or 47
days and dissection of mouse livers, isolation of RNA, genomic
DNA, and ratio of human to mouse cells in each sample was
performed as previously described [43]. The serum HCV titers,
liver viral loads and the length of time infected are given in
Table 1. The plasmid for in vitro transcription was pCV H77c and
was a gift from Dr. Jens Bukh.
Microarray expression format and data analysis
The purity of human hepatocytes was greater than 70% in all
samples used for microarrays. Microarray format, protocols for
probe labeling, and array hybridization are described at http://
expression.microslu.washington.edu. Briefly, a single experiment
comparing two mRNA samples was done with four replicate
Human 1A (V2) 22K oligonucleotide expression arrays (Agilent
Technologies) using the dye label reverse technique. This allows for
Figure 7. Immunohistochemical and confocal microscopic analysis of BiP/Grp78 expression. BiP expression was examined by either
immunohistochemistry (A–C) or confocal microscopy (D–E). Liver sections from PBS injected (A and D), replication deficient RNA injected (B) and HCV
H77c infected (C and E) donor matched chimeric mice were stained using goat anti-BiP/Grp78 alone (A–C) and developed using the Vecastain ABC
kit. Magnification 6100. Isotype controls are shown in Figure S1 E–F and are negative. For confocal microscopy (D and E), primary antibodies were
goat anti-BiP/Grp78 with mouse anti-HCV, and the secondary antibodies were donkey anti-goat alexa 488 (green), and donkey anti-mouse biotin
followed by avidin-HRP (Vector laboratories). The peroxidase was developed as before using tyramide-TMR (red). Nuclei were stained using DAPI
(blue).
doi:10.1371/journal.ppat.1000291.g007
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gene in the analyzed sample pair, standard deviation and P values
for each experiment. Spot quantitation, normalization and
application of a platform-specific error model was performed using
Agilent’s Feature Extractor software and all data was then entered
into a custom-designed database, Expression Array Manager, and
then uploaded into Rosetta Resolver System 4.0.1.0.10 (Rosetta
Biosoftware, Kirkland, WA) and Spotfire Decision Suite 7.1.1
(Spotfire, Somerville, MA). Data normalization and the Resolver
Error Model are described on the website http://expression.
microslu.washington.edu. This website is also used to publish all
primary data in accordance with the proposed MIAME standards.
Selection of genes for data analysis was based on a greaterthan 95%
probability of being differentially expressed (P#0.05) and a fold
change of 2 or greater. The resultant false positive discovery rate
was estimated to be less than 0.1% (Walters, unpublished data). We
have previously assessed the degree of cross hybridization in
chimeric samples and eliminated the small percentage of genes that
did cross react from subsequent analysis [43].
Immunohistochemistry, immunofluorescence and
confocal microscopy
In situ hybridization using FITC labeled Alu DNA probes
(InnoGenex, San Ramon, CA, USA) was performed according to
the manufacturer’s specifications, and developed using the supersen-
sitivepolymerHRP-ISHsystem(BioGenex).TUNELwasperformed
using the Apoptag Plus Peroxidase In Situ Apoptosis Detection kit
(Chemicon International, Temecula, CA, USA) according to the
manufacturer’s specifications. The number of Tunel positive nuclei is
an average of 15 fields at 2006magnification.
Haematoxylin and eosin, reticulin, Mason’s trichrome, and
periodic acid/Shiffs staining were performed according to
standard procedures [74]. The sections were graded for inflam-
matory activity and staged for fibrosis according to the modified
Batts and Ludwig scoring system [75]. The degree of fatty change
was scored as 0 (,5%), 1 (6–33%), 2 (34–66%) or 3 (.66%).
Hepatocyte ballooning and macrophages were scored on a scale of
0–4 where 0 is none and 4 is many. The lobular apoptotic body
count is an average of 5 fields counted at 1006magnification.
Figure 8. Immunohistochemical and confocal microscopic analysis of BAX expression. BAX expression was examined by either
immunohistochemistry (A–D) or confocal microscopy (E–F). Liver sections from PBS injected (A and E), replication deficient RNA injected (B) and HCV
H77c infected (C, D and F) donor matched chimeric mice were stained using rabbit anti-BAX alone (A–D) and developed using the Vecastain ABC kit.
Magnification 6100 (A–C). A magnification 6400 view is shown in D with red arrows indicating cells diffuse BAX, and black arrows indicating cells
with punctate BAX. Isotype controls are shown in Figure S3 and are negative. For confocal microscopy, primary antibodies were rabbit anti-BAX with
mouse anti-HCV, and the secondary antibodies were goat anti-rabbit alexa 488 (green), with goat anti-mouse poly-HRP, developed using tyramide-
TMR (red). Nuclei were stained using DAPI (blue). Comparison of a field from an area of liver containing only mouse cells with an HCV infected human
area is shown in Figure S3.
doi:10.1371/journal.ppat.1000291.g008
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performed on 4 mm formaldehyde fixed paraffin embedded
sections that were deparaffinized by incubation in xylene for
5 min, followed by sequential rehydration by incubating twice for
3 min in each of 100%, 95%, and 70% ethanol, followed by a
5 min incubation in distilled water. Antigen retrieval was then
performed by boiling in pH 6.0 10 mM citrate buffer for 15 min
followed by cooling for an additional 15 min.
For immunohistochemical staining with rabbit anti-FAS
antibodies (1:50, Santa Cruz), or rabbit anti-BAX (1:50, Cell
Signaling Technologies), or purified rabbit IgG isotype control,
slides were blocked in normal goat serum, washed, incubated with
the primary antibodies, washed, incubated with 3% peroxide, and
incubated with secondary goat anti rabbit poly-HRP antibodies
(Dako Cytomation). The peroxidase was developed using the DAB
Plus liquid substrate chromogen system (Dako Cytomation). For
staining with goat anti-GRP78/BiP antibodies (1:50 Santa Cruz)
or purified goat IgG isotype control, slides were blocked with
normal donkey serum, incubated with primary antibody, endog-
enous biotin was blocked using the avidin/biotin blocking kit
(Vector laboratories), and the signal was amplified using the ABC
method (Vector laboratories). The peroxidase was developed as
before. Caspase staining was performed as previously described
[6]. FAS staining was scored semi-quantitatively where 0 is no
staining, 1 (1–25%), 2 (26–50%), 3 (51–75%) and 4 (76–100%).
Caspase staining was scored semi-quantitatively as follows:
0=none, 1=focal weak, 2=diffuse weak; 3=diffuse weak and
focal strong; 4=diffuse strong. GRP78/BiP staining was scored
semi-quantitatively where 0 is no staining, 1 (1–15%), 2 (16–30%),
and 3 (31–50%). The intensity of the stain was also scored on a
scale of 0–3, where 0 is no staining and 3 is intense staining. Since
activated activated BAX has a distinct punctate staining that can
be easily distinguished form inactive BAX, active and inactive
BAX was scored on separate semi-quantitative scales. Inactive Bax
was scored in the same manner as BiP, and the scale for activated
Bax was 0 is no staining, 1(1–5%), 2 (5–10%), and 3 (10–15%).
For immunofluorescent confocal microscopy, the slides were
deparaffinized, the antigens retrieved as before, and blocked as
before. Additional blocking using mouse IgG (0.1 mg/ml) for
1 hour, followed by incubation with goat anti mouse-IgG (1 mg/
ml) overnight at 4uC was done prior to incubation with mouse anti
HCV NS3/4 diluted 1:50 (TORDJI-22, Abcam), or its isotype
control, and one of rabbit anti-FAS, BAX, GADD (Santa Cruz),
NF-kB p65 (C-20 Santa Cruz), BCL-xL (Cell Signaling Technol-
ogies), or rabbit IgG all diluted 1:50, or rabbit anti human
Albumin diluted 1:1000 (Dako Cytomation). Slides were blocked
with 3% peroxide prior to incubation with goat anti mouse poly
HRP and goat anti rabbit Alexa 488 (diluted 1:100, Molecular
Probes, Eugene, OR, USA). The peroxidase was developed using
the TSA Plus fluorescence system with tyramide-tetramethyl red
(Perkin Elmer). Mounting media (Vectastain-Vector laboratories)
contained 1 mg/ml 4,6-diamidino-2-phenylindole (DAPI). For
BiP/GRP78, the staining procedure was essentially the same,
except slides were blocked with normal donkey serum and avidin/
biotin block (Vector laboratories), the primary antibodies were
goat anti-GRP78/Bip with the mouse anti-HCV, and the
secondary antibodies were donkey anti-goat alexa 488 (Molecular
probes), and donkey anti-mouse biotin, followed by avidin-HRP
(Vector laboratories). The peroxidase was developed as before.
For co-localization of HCV antigens and TUNEL reactivity, the
In Situ Cell Death Detection kit (fluorescein) (Roche) was used,
according to the manufacturer’s specifications. The incubation
with terminal deoxynucleotidyl transferase was carried out prior to
incubation with the primary TORDJI-22 antibody. All subsequent
steps were carried out as before. Nuclei were stained using DAPI.
Confocal microscopy was carried out using a Zeiss scanning
LSM510 microscope with the 351 nm, 488, and 543 nm
excitation lines, and digital images were collected with a 1 mm
optical slice.
Accession numbers
The accession numbers for the genes/proteins discussed in this
manuscript are the following: HCV-H77c AF011751, TNF-a
X20910, FAS M67454, FASL U11821, BiP/GRP78
NM_005347, p53 AF307851, CHOP/GADD153 BC003637,
BAX NM138763, BCL-Xl Z23115, BCL-2 M14745, NF-kB
Figure 9. Confocal microscopy of HCV and CHOP/GADD153 in predominately infected or uninfected areas of HCV infected mice.
Panel (A) shows an area from an HCV infected liver that contains mostly infected cells. Panel (B) shows an area from an HCV infected liver that
contains mostly uninfected cells. Liver sections from HCV H77c infected mice were stained using rabbit anti-CHOP and mouse anti-HCV antibodies,
and the secondary antibodies were goat anti rabbit alexa 488 (green) and goat anti mouse poly-HRP, which was developed using tyramide-TMR (red).
Nuclei were stained using DAPI (blue).
doi:10.1371/journal.ppat.1000291.g009
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S57235, RIG-I AF038963, IPS-1-Q7Z434, TLR-3 U88879,
TRIF AB086380, IL28RA AY129153, CMKOR1 BC008459,
IFITM1 J04164, HLA-DRB5 NM_002125, IFIT1 M24594,
IFIT2 M14660, B2M AB021288, HLA-A D3219, HLA-B
M15470, HLA-F AY253269, HLA-G NM_002127, GBP1
BC002666, BIRC4BP X99699, CXCL11 U66096, CXCL10
X02530, CXCL9 X72755, PSMB9 NM_002800, OAS3
AF063613, OAS1 X04371, OASL AF063611, STAT1
NM_007315, G1P3 BC15603, G1P2 BC009507, IFI44 D28915,
IFI27 X67325, ANGPTL4 AF202636, NR4A1 L13740,
BDKRB2 S56772, EPO X02157, PPARGC1A AF106698,
PCK1 NM_002591, ARG2 D86724, APOA5 AF202889, AVP
M25647, CPT1A L39211, MT1A BC029475, FABP5 M94856,
RXRA X52773, SREBF1 BC057388, PLIN AB005293, C11orf11
AB014559, APOF L27050, HPX J03048, CYP1A1 BC023019,
SAA2 M26152, THRSP Y0809, SCD AF097514, PBP
NM_04139, ACSS2 AF263614, GCK AF041014, FDPS J05262,
Figure 10. Confocal microscopy of HCV and either NF-kB p65 or BCL-xL. Liver sections from PBS injected (A and C) and HCV H77c infected
(B and D) chimeric donor matched mice were stained using anti-NF-kB p65 (A and B) or BCL-xL (C and D) antibodies. Panels E and F are from non-
donor matched infected mice stained with anti-NF-kB p65 (E) or BCL-xL (F) Primary antibodies were rabbit anti-NF-kB or rabbit anti BCL-xL with
mouse anti-HCV, and the secondary antibodies were goat anti-rabbit alexa 488 (green), with goat anti-mouse poly-HRP developed using tyramide-
TMR (red). Nuclei were stained using DAPI (blue). Red arrows indicate infected cells and white arrows indicate uninfected cells. The right hand panels
are quantitation of p65 and BCL-xL levels in uninfected and HCV infected cells in HCV infected livers. For p65, 6 fields (61 infected and 59 uninfected
cells) were quantified using Metamorph software. For BCL-xL, 4 fields (44 infected and 43 uninfected cells) were quantified. To compare cells from
several fields, the average of the uninfected cells in a single field was arbitrarily set to 1 and the infected cells in that field were scaled appropriately.
Isotype controls and comparison of a field from an area of liver containing only mouse cells with an HCV infected human area are shown in Figure S4.
doi:10.1371/journal.ppat.1000291.g010
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HSD17B6 AF016509, C5 M57729, FTFD1 X69141, RDH16
NM_003708, TNFSF10 U37518, SC4MOL U93162, HMGCS1
NM_002130, IRE1 AF059198, PERK AF110146, ATF6
AB015856, hAAT X01683.
Supporting Information
Figure S1 Isotype controls for anti-HCV, FAS, and GRP78/Bip
antibodies. Liver sections from H77c infected mice were stained
using appropriate antibodies (B, D, F) or their isotype controls (A,
C, E) as described in Materials and Methods. Panels A and B are
serial sections stained using mouse IgG or mouse anti-HCV
respectively, while C and D are 4 sections apart and were stained
using rabbit IgG or rabbit anti-FAS IgG respectively, and E and F
are 7 sections apart and stained using goat IgG or goat anti-BiP
respectively.
Found at: doi:10.1371/journal.ppat.1000291.s001 (9.52 MB TIF)
Figure S2 Immunohistochemistry of FAS expression and
TUNEL reactivity. Liver sections from PBS injected (A and D),
Figure 11. HCV sensitizes infected hepatocytes to apoptosis. The pathways that link oxidative and ER stress with apoptosis are shown, as is a
potential interaction between the host cell response and apoptosis. In hepatocytes the levels of caspase 8 are low and induction of apoptosis
requires the mitochondrial amplification loop, the convergence of the stress pathways at the mitochondria and low levels of NF-kB and BCL-xL
sensitize hepatocytes to apoptosis. Proteins that we have shown are elevated in HCV infected cells are shown in red, those that do not change are
shown in yellow and those that are decreased are shown in green.
doi:10.1371/journal.ppat.1000291.g011
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infected (C and F) donor matched chimeric mice were stained
using rabbit anti-FAS (A–C), developed using the Vecastain ABC
kit and counterstained using haematoxylin. Isotype controls were
negative and are shown in Supplemental Figure 1C–D. TUNEL
(D–F) was performed using the Apoptag Plus Peroxidase In Situ
Apoptosis Detection kit and the nuclei were counterstained with
methyl green. Magnification 6400.
Found at: doi:10.1371/journal.ppat.1000291.s002 (5.37 MB TIF)
Figure S3 Isotype controls for anti-BAX antibodies and
comparison of Bax expression in an area that is predominantly
mouse. Liver sections from H77c infected mice were stained using
anti-BAX antibodies (B–D) or its isotype control (A) as described in
Materials and Methods. Panels C and D show fields of the liver
that consist of mouse cells (C) and one that is predominantly
human hepatocytes (D).
Found at: doi:10.1371/journal.ppat.1000291.s003 (5.70 MB TIF)
Figure S4 Isotype controls for anti-NF-kB antibodies and
comparison of NF-kB expression in an area that is predominantly
mouse. Liver sections from H77c infected mice were stained using
anti-NF-kB antibodies (B–D) or their isotype controls (A) as
described in Materials and Methods. Panels C and D show fields
of the liver that consist of mouse cells (C) and one that is
predominantly human hepatocytes (D).
Found at: doi:10.1371/journal.ppat.1000291.s004 (4.87 MB TIF)
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